Ana Lucrecia Woodward

Array ( [id] => 5178072 [patent_doc_number] => 20070179132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND METHODS FOR IDENTIFYING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/687541 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 53316 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179132.pdf [firstpage_image] =>[orig_patent_app_number] => 11687541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070286 [patent_doc_number] => 20070191388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'SUBSTITUTED NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND THEIR USE IN THE TREATMENT OF HUMAN DISEASES' [patent_app_type] => utility [patent_app_number] => 11/687601 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55940 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191388.pdf [firstpage_image] =>[orig_patent_app_number] => 11687601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 869154 [patent_doc_number] => 07365200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors' [patent_app_type] => utility [patent_app_number] => 11/687598 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35202 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365200.pdf [firstpage_image] =>[orig_patent_app_number] => 11687598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602611 [patent_doc_number] => 07432374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Inhibitors of macrophage migration inhibitory factor and methods for identifying the same' [patent_app_type] => utility [patent_app_number] => 11/687611 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 41995 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432374.pdf [firstpage_image] =>[orig_patent_app_number] => 11687611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337989 [patent_doc_number] => 20090054453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Novel Tetralins as 5-HT6 Modulators' [patent_app_type] => utility [patent_app_number] => 12/293176 [patent_app_country] => US [patent_app_date] => 2007-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21582 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054453.pdf [firstpage_image] =>[orig_patent_app_number] => 12293176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070288 [patent_doc_number] => 20070191390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'SUBSTITUTED HETEROCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/685398 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15307 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191390.pdf [firstpage_image] =>[orig_patent_app_number] => 11685398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989387 [patent_doc_number] => 20070155728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Substituted Heterocyclic Compounds' [patent_app_type] => utility [patent_app_number] => 11/683917 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16997 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155728.pdf [firstpage_image] =>[orig_patent_app_number] => 11683917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220353 [patent_doc_number] => 20070161664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'THERAPEUTIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/682945 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18565 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161664.pdf [firstpage_image] =>[orig_patent_app_number] => 11682945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016670 [patent_doc_number] => 20070259879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Piperazine and piperidine biaryl derivatives' [patent_app_type] => utility [patent_app_number] => 11/714539 [patent_app_country] => US [patent_app_date] => 2007-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37826 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259879.pdf [firstpage_image] =>[orig_patent_app_number] => 11714539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322634 [patent_doc_number] => 07517867 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Topoisomerase-targeting agents' [patent_app_type] => utility [patent_app_number] => 11/714680 [patent_app_country] => US [patent_app_date] => 2007-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11782 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517867.pdf [firstpage_image] =>[orig_patent_app_number] => 11714680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220330 [patent_doc_number] => 20070161641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/714047 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44243 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161641.pdf [firstpage_image] =>[orig_patent_app_number] => 11714047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 71890 [patent_doc_number] => 07754725 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'Dihydroxyphenyl isoindolymethanones' [patent_app_type] => utility [patent_app_number] => 11/680818 [patent_app_country] => US [patent_app_date] => 2007-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64534 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754725.pdf [firstpage_image] =>[orig_patent_app_number] => 11680818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574751 [patent_doc_number] => 07829713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Therapeutic piperazines' [patent_app_type] => utility [patent_app_number] => 11/679782 [patent_app_country] => US [patent_app_date] => 2007-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19461 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829713.pdf [firstpage_image] =>[orig_patent_app_number] => 11679782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5113650 [patent_doc_number] => 20070197566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'NOVEL PYRAZOLYLQUINAZOLINONES AS POTASSIUM CHANNEL OPENERS' [patent_app_type] => utility [patent_app_number] => 11/675724 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7606 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197566.pdf [firstpage_image] =>[orig_patent_app_number] => 11675724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691423 [patent_doc_number] => 20070232610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Novel compounds that are ERK inhibitors' [patent_app_type] => utility [patent_app_number] => 11/705709 [patent_app_country] => US [patent_app_date] => 2007-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68737 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232610.pdf [firstpage_image] =>[orig_patent_app_number] => 11705709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5023570 [patent_doc_number] => 20070149536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Inhibitors of Akt activity' [patent_app_type] => utility [patent_app_number] => 11/705677 [patent_app_country] => US [patent_app_date] => 2007-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19645 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149536.pdf [firstpage_image] =>[orig_patent_app_number] => 11705677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101867 [patent_doc_number] => 20070185129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'ACID ADDITION SALTS OF THIENOPYRANCARBOXAMIDE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/671350 [patent_app_country] => US [patent_app_date] => 2007-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7647 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185129.pdf [firstpage_image] =>[orig_patent_app_number] => 11671350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253989 [patent_doc_number] => 20070135445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Bicyclic Indolyl Derivatives and Methods for Their Use as Serotonergic Agents' [patent_app_type] => utility [patent_app_number] => 11/623225 [patent_app_country] => US [patent_app_date] => 2007-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10608 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135445.pdf [firstpage_image] =>[orig_patent_app_number] => 11623225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120685 [patent_doc_number] => 20070142400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine' [patent_app_type] => utility [patent_app_number] => 11/652092 [patent_app_country] => US [patent_app_date] => 2007-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11009 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142400.pdf [firstpage_image] =>[orig_patent_app_number] => 11652092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4507939 [patent_doc_number] => 07915260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Urotensin II receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/651848 [patent_app_country] => US [patent_app_date] => 2007-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 96237 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915260.pdf [firstpage_image] =>[orig_patent_app_number] => 11651848 [rel_patent_id] =>[rel_patent_doc_number] =>)